The evaluation and treatment of graves ophthalmopathy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22443978.
- Also identified by DOI 10.1016/j.mcna.2012.01.014 and PMC identifier 3898790.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Optimum care of the patient with Graves ophthalmopathy (GO) is achieved through teamwork between the endocrinologist and ophthalmologist, with input from ancillary specialists as needed. Clinical evaluation should include determination of both the severity and the activity of the disease. It is important to assess early in the evaluation the impact of the disease on the patient's quality of life and their priorities and expectations regarding management. Once this information has been gathered, careful discussion between patient and physicians can define the management plan. This article reviews the pathophysiology, epidemiology, evaluation, and management of GO.
Medical subject headings
- Graves Ophthalmopathy